SB 26-113 would shift Colorado’s regulation of recovery residences from a certification-based system to a licensing system administered by the Behavioral Health Administration (BHA), beginning July 1, 2027. The bill defines “recovery residence” and excludes several types of housing and facilities, including permanent supportive housing, shelters and short-term emergency housing, licensed behavioral health residential treatment, health facilities, and certain reentry-focused programs. It also repeals the current recovery residence certifying framework and related provisions as the new licensing regime takes effect.
Under the bill, recovery residences must apply for and maintain a BHA license, comply with minimum operating standards set by rule, and submit to inspections, reporting, and background-check requirements. The BHA must adopt rules by May 1, 2027 covering resident rights, governance, records, staffing, admissions and discharge, physical standards, incident reporting, and enforcement. The bill also creates provisional licensing, annual renewal, public posting of licensed residences, and civil penalties for operating without a license. It further bars referral or contracting with unlicensed recovery residences by health-care providers, managed care entities, health facilities, and governmental entities, and it protects residents who use prescribed medication-assisted treatment or other prescribed medications.
The bill’s impact on state law is substantial: it amends multiple sections of the Colorado Revised Statutes to move oversight of recovery residences into the BHA’s licensing authority, fund that oversight through licensing fees, and sunset the new regulatory part in 2033. It also updates related statutes on behavioral health administration, housing assistance, zoning declarations, and liquor-related stakeholder rules to reference the new definition and regulatory structure. In practical terms, the bill increases state oversight of recovery residences, standardizes operating requirements, and creates enforcement tools aimed at resident safety and reducing abusive or fraudulent practices.
The overall sentiment reflected in the bill’s structure is supportive of stronger regulation and consumer protection, with a clear emphasis on safety, accountability, and access to recovery housing. Although no committee transcripts or recorded votes were provided, the bill’s detailed licensing framework, public disclosure provisions, and restrictions on kickbacks and referral practices suggest a policy response to concerns about unregulated or exploitative recovery housing operations. The bill also appears designed to preserve access to recovery residences for people using medication-assisted treatment and for individuals with criminal justice involvement, indicating an intent to avoid exclusionary practices.
The main points of contention likely center on the added regulatory burden for recovery residence operators, the cost of licensing and background checks, and the BHA’s expanded enforcement authority, including inspections, penalties, and public reporting. Another likely issue is the transition from certification to licensing, especially for residences already operating under the prior system and for smaller providers that may need time to meet new standards. At the same time, the bill explicitly limits some common grounds for exclusion, such as prior criminal history or participation in medication-assisted treatment, which may be welcomed by advocates but could be debated by operators concerned about safety, liability, or program autonomy.
The bill repeals the existing recovery residence certification framework and replaces it with a BHA licensing regime effective July 1, 2027. It amends Colorado’s behavioral health statutes to create new licensing, inspection, reporting, fee, enforcement, and confidentiality provisions for recovery residences, while also updating related statutes on housing assistance, zoning, and behavioral health administration to align with the new system. Recovery residences, health-care providers, managed care entities, and governmental purchasers or referrers are directly affected, as referrals and contracts will be limited to licensed residences.
The bill’s overall tone is protective and regulatory, reflecting support for stronger state oversight of recovery residences and for resident safety, transparency, and access to treatment-compatible housing. Even without recorded committee testimony or votes, the bill’s detailed standards and consumer protections suggest broad concern about unregulated recovery housing and a legislative preference for formal oversight. At the same time, the transition to licensing and the new compliance obligations likely generated practical concerns among operators about cost, timing, and administrative burden.
Likely areas of contention include whether the new licensing requirements are too burdensome for recovery residence operators, whether BHA inspections and enforcement are sufficiently flexible, and how quickly existing certified residences can comply with the new standards. Operators may also object to background-check requirements, fee-funded regulation, and restrictions on referrals or contracts unless a residence is licensed. On the other hand, advocates for residents and treatment access are likely to support the bill’s anti-kickback provisions, medication-assisted treatment protections, and public reporting requirements as necessary safeguards against exploitation and unsafe housing.